Question 1 Calculate the Coefficient of variation (percent) for a set of data where the mean (X) = 89 mg/dL and 2SD (s) = 14 mg/dL.
a. 7%
b. 7.8%
c. 7.9%
d. 14%
Question 2 A batch of test results is out-of-control. What should you do first?
a. Report the results to the physician first, and then look for the trouble.
b. Repeat the tests with a new lot of standards (calibrators).
c. Follow the "out of control" procedure specified for the test method.
d. Repeat the tests with a new lot of reagents.
Question 3 A new standard (calibrator) has been prepared in error at a lower concentration than that required for the test. How would such an error appear on a quality control chart?
a. Down ward shift
b. Upward shift
c. Down ward trend
d. Upward trend
Question 4 On a QC chart, when would a statistical out of control situation requiring corrective action be suspected?
a. When 6 successive plots fall above and below the mean within +/- 1s
b. When 6 successive plots fall above and below the mean within +/- 2s
c. When one plot falls within the area of +/- 2s to 3s within a 20 consecutive day span
d. When one plot falls outside the area of +/-3s within a 20 consecutive day span
Question 5 Which term refers to the measure of scatter of experimental data around the mean of a Gaussian (normal) distribution curve?
a. Mean
b. Coefficient of variation
c. Mode
d. Standard deviation
1. Coefficient variation in percent = SD/ mean x 100
Here 2SD = 14
SD = 14/2 = 7
Mean = 89
Coefficient variation = 7/89 x 100 = 7.86% or 7.9%
So the answer is (b) 7.9%
2. If the batch of test results is out of control then Follow
the "out-of-control" procedure
specified for the test method.
So the answer is (c)
3. such an error appear on a quality control chart as upward shift.
So the answer is ( b)
4. The answer is (d)
5. Standard deviation refers to the measure of scatter of experimental data around the mean of a Gaussian distribution curve.
Question 1 Calculate the Coefficient of variation (percent) for a set of data where the mean...
Please read the article bellow and discuss the shift in the company's approach to genetic analysis. Please also discuss what you think about personal genomic companies' approaches to research. Feel free to compare 23andMe's polices on research with another company's. Did you think the FDA was right in prohibiting 23andMe from providing health information? These are some sample talking points to get you thinking about the ethics of genetic research in the context of Big Data. You don't have to...